Open Access


Read more
image01

Online Manuscript Submission


Read more
image01

Submitted Manuscript Trail


Read more
image01

Online Payment


Read more
image01

Online Subscription


Read more
image01

Email Alert



Read more
image01

Original Research Article | OPEN ACCESS

Influence of miR155 on allergic conjunctivitis in mice via regulation of NF-κB signal pathway

Mengtian Bai1-5, Yan Li1-5, Yun Li1-6, Zhulin Hu1-5

1Department of Ophthalmology, Fourth Affiliated Hospital of Kunming Medical University; 2Yunnan Eye Institute; 3Key Laboratory of Yunnan Province for the Prevention and Treatment of Ophthalmology; 4Provincial Innovation Team for Cataract and Ocular Fundus Disease, The Second People's Hospital of Yunnan Province; 5Expert Workstation of Yao Ke; 6Department of Oncology, First Affiliated Hospital of Kunming Medical University, Kunming, China.

For correspondence:-  Zhulin Hu   Email: ceby54@163.com

Accepted: 28 July 2019        Published: 27 August 2019

Citation: Bai M, Li Y, Li Y, Hu Z. Influence of miR155 on allergic conjunctivitis in mice via regulation of NF-κB signal pathway. Trop J Pharm Res 2019; 18(8):1603-1608 doi: 10.4314/tjpr.v18i8.5

© 2019 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To investigate the effect of miR-155 on allergic conjunctivitis (AC) in mice, and to elucidate the mechanism of action.
Methods: Sixty (60) Balb/c mice were randomly divided into three groups with 20 mice per group. Ovalbumin (OVA) was used to induce experimental model of AC in mice. Mice in the AC+miR-155 siRNA group were given miR-SiRNA once daily for 2 weeks before inducing AC. The expressions of miR-155 in conjunctival tissue of the control and AC groups were assayed with reverse transcription-polymerase chain reaction (RT-PCR). In addition, anti-OVA IgE antibody, eotaxin, IL-13 and IFN-γ levels were determined using ELISA (enzyme-linked immunosorbent assay). The regulatory effect of miR-155 on the NF-κB signal pathway in mice conjunctiva tissue with AC was determined using immunoblotting.
Results: Higher miR-155 expression was seen in serum of AC group than in that of control group (p < 0.05). Inhibition of miR-155 mitigated AC-induced pathological injury, reduced infiltration of eosinophils, lowered serum levels of anti-AVO IgE antibody eotaxin and Il-13, and increased IFN-γ level (p < 0.05). Phosphorylation of P65 of conjunctiva tissue of AC mice was blocked after inhibition of miR-155.
Conclusion: The inhibition of miR-155 ameliorates AC in mice most likely via a mechanism related to the inhibition of phosphorylation of P65. This provides a theoretical basis for new drug research and development.

Keywords: Allergic conjunctivitis, Mice, miR-155, Phosphorylation of P65, Ovalbumin

Impact Factor
Thompson Reuters (ISI): 0.523 (2021)
H-5 index (Google Scholar): 39 (2021)

Article Tools

Share this article with



Article status: Free
Fulltext in PDF
Similar articles in Google
Similar article in this Journal:

Archives

2024; 23: 
1,   2,   3,   4
2023; 22: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2022; 21: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2021; 20: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2020; 19: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2019; 18: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2018; 17: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2017; 16: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2016; 15: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2015; 14: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2014; 13: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2013; 12: 
1,   2,   3,   4,   5,   6
2012; 11: 
1,   2,   3,   4,   5,   6
2011; 10: 
1,   2,   3,   4,   5,   6
2010; 9: 
1,   2,   3,   4,   5,   6
2009; 8: 
1,   2,   3,   4,   5,   6
2008; 7: 
1,   2,   3,   4
2007; 6: 
1,   2,   3,   4
2006; 5: 
1,   2
2005; 4: 
1,   2
2004; 3: 
1
2003; 2: 
1,   2
2002; 1: 
1,   2

News Updates